Kenji Tanabe

7PUBLICATIONS
12CO-AUTHORS
Phylogeny and comparative analysisCancer therapy (excl. chemotherapy and radiation therapy)Stochastic analysis and modellingPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 18, 2026
Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup Results.

Kenji Tanabe, Soichiro Yoshida, Wei Chen

|Feb 09, 2026
Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Time-Dependent Analysis of Reconstructed Individual Patient Data From the PEACE-3 Trial.

Wei Chen, Soichiro Yoshida, Shugo Yajima

|Jan 16, 2026
Non-Proportional Hazards Analysis of the RADIOSA Trial Using Reconstructed Individual Patient Data.

Kenji Tanabe, Soichiro Yoshida, Wei Chen

|Dec 22, 2025
Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study).

Takahiko Soma, Hajime Tanaka, Yuki Nakamura

|Apr 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study).

Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura

|Jun 01, 2024
Risk factors for the long-term persistent genitourinary toxicity after stereotactic body radiation therapy for localized prostate cancer: A single-center, retrospective study of 306 patients.

Kenji Tanabe, Shuichiro Kobayashi, Takashi Tamiya

Pageof 2

Frequent Collaborators

4 joint publications

Soichiro Yoshida

3 joint publications

Hajime Tanaka

3 joint publications

Yasuhisa Fujii

2 joint publications

Shugo Yajima